“Market Withdrawals” of Medicines in Germany After AMNOG: A Comparison of HTA Ratings and Clinical Guideline Recommendations
Health Economics Review - Germany
doi 10.1186/s13561-018-0209-3
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 18, 2018
Authors
Publisher
Springer Science and Business Media LLC